Roche (RHHBY) and Novartis (NVS) tout their U.S. investments as President Donald Trump imposes new 100% pharma tariffs. Read ...

Eli Lilly said on Thursday the U.S. Food and Drug Administration has approved its treatment for a form of advanced breast ...

Trump’s threat of a 100% tariff on imported branded or patented drugs sounds dramatic, yet, pharma stocks were mostly in the ...

Eli Lilly (LLY) remains a strong growth company, driven by leadership in the booming GLP-1 and diabetes drug markets despite ...

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 3.1% in the afternoon session after the company halted a ...

If you have been keeping an eye on Eli Lilly’s stock, you are not alone, and you are probably wondering if now is the right ...

Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ ...

Celltrion Inc. said in a regulatory filing in South Korea on Tuesday its U.S. subsidiary has acquired Imclone Systems LLC ...

South Korean biopharmaceutical company Celltrion said it would invest at least $1 billion to acquire a plant from Eli Lilly ...

Eli Lilly and Company (NYSE: LLY) is one of the 10 Best AI Stocks to Buy According to Goldman Sachs. On September 18, Wells ...

Eli Lilly's GLP-1 Pill Just Beat Out Novo Nordisk's in a Test. Here's 1 Thing Investors Need to Know. The secondary endpoints ...